Treating HCV With DAA: Fear Not the Perceived Threat of HCC

Liver Transplantation - United States
doi 10.1002/lt.24959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Reciprocal Interaction Between HCV Direct-Acting Anti-Virals (DAA) and Hepatocellular Carcinoma (HCC)-a Negative Impact of HCC on Sustained Virologic Response Not of DAA on HCC

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)

Scientific Reports
Multidisciplinary
2019English

A Strong Message Is Needed to Address the Issue of HCC Recurrence After DAA Therapy

Journal of Hepatology
Hepatology
2016English

Prognostic Analysis of HCC With HCV Infection Using Epithelial-Mesenchymal Transition Gene Profiles

Journal of Surgical Research
Surgery
2020English

The Complex Association of Virus- And Host-Related Factors With HCC Rate Following HCV Clearance

Journal of Clinical Microbiology
Microbiology
2018English

Fear Filter: Visualising the UK Terror Threat Level

2018English

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings

Hepatology
MedicineHepatology
2018English

How Effective and How Durable Is DAA‐therapy in HCV‐infected Drug Users?

Liver International
Hepatology
2019English

Development of Anxiety: The Role of Threat Appraisal and Fear Learning

Depression and Anxiety
PsychiatryClinical PsychologyMental Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy